Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum, Henry; Haas, Steven Joseph; Eichhorn, Eric; Ghali, Jalal; Gilbert, Edward; Lechat, Philippe; Packer, Milton; Roecker, Ellen; Verkenne, Patricia; Wedel, Hans; Wikstrand, John

Krum, Henry; Haas, Steven Joseph; Eichhorn, Eric; Ghali, Jalal; Gilbert, Edward; Lechat, Philippe; Packer, Milton; Roecker, Ellen; Verkenne, Patricia; Wedel, Hans; Wikstrand, John.

Affiliation

Krum H; NHMRC Centre of Clinical Research Excellence in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University Central and Eastern Clinical School, Alfred Hospital, Melbourne 3004, Australia. henry.krum@med.monash.edu.au

Eur Heart J ; 26(20): 2154-8, 2005 Oct.

Article in En | MEDLINE | ID: mdl-16014644

Subject(s)

Adrenergic beta-Antagonists/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Heart Failure/drug therapy; Cause of Death; Chronic Disease; Heart Failure/mortality; Hospitalization/statistics & numerical data; Humans; Randomized Controlled Trials as Topic; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Adrenergic beta-Antagonists / Heart Failure Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Eur Heart J Year: 2005 Type: Article Affiliation country: Australia

Search on Google

XML

PubMed Links